DJ Biogen Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ slid 1.01% to $200.14 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.02% to 7,413.18 and the Dow Jones Industrial Average rising 0.51% to 52,210.08.
The stock's fall snapped a two-day winning streak.
Biogen Inc. closed 8.91% short of its 52-week high of $219.72, which the company achieved on June 29th.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 0.97% to $265.95, Pfizer Inc. $(PFE)$ rose 0.53% to $24.67, and AbbVie Inc. $(ABBV)$ fell 0.94% to $256.91.
Trading volume (762,497) remained 517,493 below its 50-day average volume of 1.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 27, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
July 27, 2026 16:58 ET (20:58 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments